 |
The lipodystrophy syndrome among HIV infected children in Rio de Janeiro, Brazil
L. Papi1, R.H. Oliveira2, L. Evangelista2, T. Abreu2, A.C. Frota2, C.B. Hofer3
1Universidade Federal do Rio de Janeiro, Preventive Medicine, Rio de Janeiro, Brazil, 2Universidade Federal do Rio de Janeiro, Pediatrics, Rio de Janeiro, Brazil, 3Universidade de Federal do Rio de Janeiro, Preventive Medicine - Infectious Diseases, Rio de Janeiro, Brazil
Background: The lipodystrophy
syndrome (SLHIV) is an important side effect in patients with HIV/AIDS using
antiretrovirals including the pediatric population, however there is scarce
data in this specific age group. The aim of this study is to evaluate SLHIV in children and assess possible factors associated with it. Methods: cross-sectional
study aimed to describe lipodystrophy syndrome in Brazilian children with
HIV/AIDS, aged 2-15 years old, and to evaluate risk factors associated with it.
Patients with SLHIV were defined using the parameters of the European Pediatric
Lipodystrophy Group: presence of peripheral lipoatrophy or centripetal
lipohypertrophy on physical exam, and may occur in conjunction with laboratory
abnormalities of cholesterol and triglycerides). Patients were evaluated using
a structured questionnaire; physical exam; and laboratory tests were collected.
A bivariate analysis was performed using t-Student or Chi-square tests and
multivariate logistic regression was used on the multivariate analysis. Results: We analyzed 90
children, all in use of HAART. The mean age was 124.2 months, and 44 were boys
(48.9%). 48 (53.3%) showed clinical changes consistent with lipodystrophy (31
with lipohypertrophy, 20 with lipoatrophy, and 18 with both). 10 patients
showed abnormal cholesterol (and 7 with clinical manifestations), and 17 with
abnormal triglycerides (8 with clinical manifestations). Among the risk factors
studied, low per capita income (P = 0.065), past use of non-nucleotide reverse
transcriptase inhibitors (P = 0.1845), low baseline CD4 (P = 0.0572),
inadequate consumption of sugars and fats (P = 0.051), current viral load high
(P= 0.0543) were evaluated on the multivariate analysis. The independent risk
factor associated with SLHIV was baseline CD4 cells percent (OR=0.94, 95%CI=
0.90-0.99). Conclusions: More than half of
the children fulfilled the SLHIV criteria. Initial CD4 percent was associated
with SLHIV, probably immune reconstitution phenomena were associated with this
syndrome.
Back -
Back to the Programme-at-a-Glance
|
|